Montreal, May 2023. CandorVision celebrates 10 Years of Patient Success with HYLO® and HYLO® Gel lubricating eye drops. They were the first multidose, preservative-free, phosphate-free eye drops, and they continue to provide long-lasting dry eye relief for Canadian patients of all ages today!
CandorVision’s HYLO® family of lubricating eye drops have transformed the lives of countless patients suffering from dry eye disease, allergies or recovering from eye surgeries.
"We are thrilled to celebrate this milestone anniversary and grateful to Canadian health professionals for their trust and support. Working together, we continue to make a difference in the lives of so many patients." said Dr. Frank Heidemann, CEO & Founder of CandorVision. "With the introduction of HYLO® ten years ago, we raised the standard of care for Canadian dry eye patients to a new level. At the same time, HYLO® significantly reduced the cost of preservative-free lubrication compared to uni-dose/single dose eye drops."
HYLO®’s cutting-edge German technology and high-quality ingredients combined with CandorVision’s patient-centered approach has resulted in the adoption of HYLO® as the go-to, preservative-free dry eye drops for ophthalmologists, optometrists, opticians and other healthcare professionals, including pharmacists. HYLO® helps them make their practices more efficient, freeing up chair time to allow them to focus on what they do best: delivering care to their patients.
The German-engineered HYLO® bottle provides both convenience and practicality: its airless multidose delivery system keeps the contents sterile without the need for chemical preservatives, and it precisely dispenses at least 300 single drops, one drop at a time. The unique high-quality, high-molecular weight Sodium Hyaluronate in HYLO® provides optimal lubrication of the cornea and long-lasting dry eye relief without affecting clear vision. Not only are HYLO® and HYLO® Gel preservative-free, they are also phosphate-free and approved for post-surgical and long-term use.
Committed to research and innovation, CandorVision has been expanding its offering of ophthalmics addressing unmet needs and improving the health and well-being of millions of Canadian patients. Growing rapidly, CandorVision has consistently received high marks in patient testimonials, and praised for its customer service and operational excellence.
Beyond science, CandorVision has been committed to supporting those in need. Apart from various ad-hoc projects, CandorVision has been a long-term supporter of the Sjoegrens’s Society of Canada and the CNIB / Vision Loss Rehabilitation eye van. Mindful of its loyal users’ economic needs, CandorVision has also implemented a patient program as of 2020.
“We continue to be committed to providing the highest quality of service to patients and health professionals alike.” said Tatiana Shchukina, VP of Operations & Administration at CandorVision. "As we look ahead to the next decade, we are confident that CandorVision will continue to have a positive impact on the lives of those in our local communities and nationwide."